Shengli Xue

40PUBLICATIONS
99CO-AUTHORS
Haematological tumoursMedical molecular engineering of nucleic acids and proteinsCardiovascular medicine and haematology not elsewhere classifiedApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (40)

|Jul 14, 2026
Low-Dose Chidamide Maintenance Therapy After Hematopoietic Stem Cell Transplantation for T-Cell Acute Lymphoblastic Leukemia: A Case Series.

|Jun 26, 2026
Inhibition of ADSS2-mediated de novo AMP biosynthesis re-sensitizes acute myeloid leukemia to BH3 mimetics.

|Mar 05, 2026
Haploidentical Hematopoietic Stem Cell Transplantation With Anti-Thymocyte Globulin in the Treatment of Older Adults With Hematological Malignancy.

Xin Kong, Jingjing Han, Yin Liu

|Feb 04, 2026
Coexistence of BCR::ABL1 with IKZF1::ETV6 fusion in an adult patient with acute B-lymphoblastic leukemia.

Kai-Wen Tan, Yi Xu, Yuan-Hong Huang

|Nov 12, 2025
The interleukin-6 connection: Understanding cytomegalovirus reactivation following CAR-T-cell therapy.

Linghao Li, Zihao Wang, Chongsheng Qian

|Oct 28, 2025
IL-6 knockdown anti-CD19 CAR-T cells (ssCART-19) for patients with relapsed or refractory acute lymphoblastic leukemia: phase 1 trial.

Sheng-Li Xue, Mei-Jing Liu, Chong-Sheng Qian

Pageof 7

Frequent Collaborators

13 joint publications

Haiping Dai

12 joint publications

Depei Wu

10 joint publications

Xiaowen Tang

10 joint publications

Ying Wang